Logo image of ALKAL.PA

KALRAY SADIR (ALKAL.PA) Stock Fundamental Analysis

EPA:ALKAL - Euronext Paris - Matif - FR0010722819 - Common Stock - Currency: EUR

0.637  +0.02 (+2.58%)

Fundamental Rating

2

We assign a fundamental rating of 2 out of 10 to ALKAL. ALKAL was compared to 56 industry peers in the Semiconductors & Semiconductor Equipment industry. ALKAL has a bad profitability rating. Also its financial health evaluation is rather negative. ALKAL is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

ALKAL had negative earnings in the past year.
ALKAL had a positive operating cash flow in the past year.
ALKAL had negative earnings in each of the past 5 years.
In the past 5 years ALKAL reported 4 times negative operating cash flow.
ALKAL.PA Yearly Net Income VS EBIT VS OCF VS FCFALKAL.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -10M -20M -30M

1.2 Ratios

ALKAL has a Return On Assets of -26.40%. This is amonst the worse of the industry: ALKAL underperforms 94.64% of its industry peers.
ALKAL has a Return On Equity of -67.18%. This is amonst the worse of the industry: ALKAL underperforms 92.86% of its industry peers.
Industry RankSector Rank
ROA -26.4%
ROE -67.18%
ROIC N/A
ROA(3y)-19.53%
ROA(5y)-23.68%
ROE(3y)-41.1%
ROE(5y)-44.77%
ROIC(3y)N/A
ROIC(5y)N/A
ALKAL.PA Yearly ROA, ROE, ROICALKAL.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500 1K 1.5K 2K

1.3 Margins

ALKAL has a better Gross Margin (114.61%) than 100.00% of its industry peers.
ALKAL's Gross Margin has declined in the last couple of years.
The Profit Margin and Operating Margin are not available for ALKAL so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 114.62%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.53%
GM growth 5Y-27.47%
ALKAL.PA Yearly Profit, Operating, Gross MarginsALKAL.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2017 2018 2019 2020 2021 2022 2023 2024 0 500 -500 -1K

More info and screens

1

2. Health

2.1 Basic Checks

ALKAL does not have a ROIC to compare to the WACC, probably because it is not profitable.
ALKAL has more shares outstanding than it did 1 year ago.
Compared to 5 years ago, ALKAL has more shares outstanding
Compared to 1 year ago, ALKAL has a worse debt to assets ratio.
ALKAL.PA Yearly Shares OutstandingALKAL.PA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2M 4M 6M 8M 10M
ALKAL.PA Yearly Total Debt VS Total AssetsALKAL.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M

2.2 Solvency

ALKAL has an Altman-Z score of -1.25. This is a bad value and indicates that ALKAL is not financially healthy and even has some risk of bankruptcy.
ALKAL has a Altman-Z score of -1.25. This is amonst the worse of the industry: ALKAL underperforms 91.07% of its industry peers.
A Debt/Equity ratio of 0.25 indicates that ALKAL is not too dependend on debt financing.
ALKAL has a Debt to Equity ratio (0.25) which is in line with its industry peers.
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Altman-Z -1.25
ROIC/WACCN/A
WACC9.86%
ALKAL.PA Yearly LT Debt VS Equity VS FCFALKAL.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20M -20M 40M

2.3 Liquidity

A Current Ratio of 0.62 indicates that ALKAL may have some problems paying its short term obligations.
ALKAL has a worse Current ratio (0.62) than 92.86% of its industry peers.
ALKAL has a Quick Ratio of 0.62. This is a bad value and indicates that ALKAL is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Quick ratio, with a value of 0.53, ALKAL is doing worse than 92.86% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.62
Quick Ratio 0.53
ALKAL.PA Yearly Current Assets VS Current LiabilitesALKAL.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M

More info and screens

6

3. Growth

3.1 Past

The earnings per share for ALKAL have decreased strongly by -57.41% in the last year.
ALKAL shows a decrease in Revenue. In the last year, the revenue decreased by -3.89%.
ALKAL shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 81.37% yearly.
EPS 1Y (TTM)-57.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.61%
Revenue 1Y (TTM)-3.89%
Revenue growth 3Y157.5%
Revenue growth 5Y81.37%
Sales Q2Q%31.62%

3.2 Future

Based on estimates for the next years, ALKAL will show a very strong growth in Earnings Per Share. The EPS will grow by 33.40% on average per year.
ALKAL is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 45.29% yearly.
EPS Next Y42.69%
EPS Next 2Y33.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-83.64%
Revenue Next 2Y-59.55%
Revenue Next 3Y67.4%
Revenue Next 5Y45.29%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
ALKAL.PA Yearly Revenue VS EstimatesALKAL.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 50M 100M 150M
ALKAL.PA Yearly EPS VS EstimatesALKAL.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 -0.5 -1 -1.5 -2 -2.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALKAL. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALKAL. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
ALKAL.PA Price Earnings VS Forward Price EarningsALKAL.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
ALKAL.PA Per share dataALKAL.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 1 -1 2 -2 3

4.3 Compensation for Growth

A more expensive valuation may be justified as ALKAL's earnings are expected to grow with 33.40% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y33.4%
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for ALKAL!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

KALRAY SADIR

EPA:ALKAL (7/23/2025, 7:00:00 PM)

0.637

+0.02 (+2.58%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-09 2025-07-09
Earnings (Next)09-17 2025-09-17
Inst Owners6.57%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap7.34M
Analysts40
Price Target0.51 (-19.94%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-80.3%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.3
P/FCF N/A
P/OCF 2.6
P/B 0.21
P/tB N/A
EV/EBITDA N/A
EPS(TTM)-2.16
EYN/A
EPS(NY)-1.27
Fwd EYN/A
FCF(TTM)-2.71
FCFYN/A
OCF(TTM)0.25
OCFY38.46%
SpS2.15
BVpS3
TBVpS-1.99
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -26.4%
ROE -67.18%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 114.62%
FCFM N/A
ROA(3y)-19.53%
ROA(5y)-23.68%
ROE(3y)-41.1%
ROE(5y)-44.77%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-43.53%
GM growth 5Y-27.47%
F-Score2
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.25
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 157.9%
Cap/Sales 137.12%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 0.62
Quick Ratio 0.53
Altman-Z -1.25
F-Score2
WACC9.86%
ROIC/WACCN/A
Cap/Depr(3y)126.32%
Cap/Depr(5y)90.91%
Cap/Sales(3y)102.68%
Cap/Sales(5y)192.5%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.61%
EPS Next Y42.69%
EPS Next 2Y33.4%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.89%
Revenue growth 3Y157.5%
Revenue growth 5Y81.37%
Sales Q2Q%31.62%
Revenue Next Year-83.64%
Revenue Next 2Y-59.55%
Revenue Next 3Y67.4%
Revenue Next 5Y45.29%
EBIT growth 1Y-77.94%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year88.62%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-35.75%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y231.64%
OCF growth 3YN/A
OCF growth 5YN/A